Samsara BioCapital GP, LLC - 12 Feb 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role: 10%+ Owner
Signature: Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Issuer symbol: MLYS
Transactions as of: 12 Feb 2024
Net transactions value: +$7,499,992
Form type: 4
Filing time: 14 Feb 2024, 21:06:11 UTC
Previous filing: 16 Nov 2023
Next filing: 29 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLYS	Common Stock	Purchase	$7,499,992	+555,555	+12%	$13.50	5,074,916	12 Feb 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara BioCapital, L.P. ("Samsara LP") and may be deemed to beneficially own the shares held by Samsara LP. Samsara LLC disclaims beneficial ownership in these shares except to the extent of its pecuniary interest therein.